Web-based survey of Italian Association of Clinical Endocrinologists (AME) members comparing 2022 versus current attitudes and clinical practices for obesity management, assessing whether educational initiatives and the arrival of GLP-1 RA/tirzepatide pharmacotherapy have changed endocrinologist engagement with obesity treatment in Italy. Measures practice evolution over a period of significant pharmacotherapy expansion. Documents the shift in Italian endocrinologist obesity management practices following the availability of tirzepatide and GLP-1 RA therapies—quantifying how pharmaceutical innovation drives physician practice change and identifying remaining barriers to proactive obesity management in Italian endocrinology practice.
Chianelli, Marco; Busetto, Luca; Attanasio, Roberto; Guglielmi, Rinaldo; Cozzi, Renato; Grimaldi, Franco; Frasoldati, Andrea; Persichetti, Agnese; Papini, Enrico; Nicolucci, Antonio